References
Govindan R, Page N, Morgensztern D et al (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the SEER database. J Clin Oncol 24:4539–4544
Mascaux C, Paesmans M, Berghmans et al (2000) A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and metaanalysis. Lung Cancer 30:23–36
Sundstrom S, Bremnes RM, Kaasa S (2002) Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up. J Clin Oncol 20:4665–4672
Amarasena I, Walters JA, Wood-Baker R, Fong K (2008) Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. Cochrane Database Syst Rev (4):CD006849
Pignon JP, Arriagada R, Ihde DC et al (1992) A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618–1624
Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890–895
Turrisi AT, Kim K, Blum R et al (1999) Twicedaily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265–271
De Ruysscher D, Pijls-Johannesma M, Bentzen SM et al (2006) Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 24:1057–1063
Auperin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341:476–484
Artal-Cortés A, Gómez-Codina J, González-Larriba JL et al (2004) Prospective randomized trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small cell lung cancer. Clin Lung Cancer 5:360–365
Medical Research Council Lung Cancer Working Party (1996) Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Lancet 348:563–566
Dómine M, Casado V, Rubio G et al (2008) New drugs for small cell lung cancer. Cancer Chemother Rev 3:212–222
Hanna N, Bunn PA Jr, Langer C et al (2006) Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 24:2038–2043
Eckardt JR, Von Pawel J, Papai Z et al (2006) Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapynaive patients with extensive-disease small-cell lung cancer. J Clin Oncol 24:2044–2051
Jeremic B, Shibamoto Y, Nikolic N et al (1999) Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 17:2092–2099
Inoue A, Sugawara S, Yamazaki K et al (2008) Randomized, phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402. J Clin Oncol 26:5401–5406
Slotman B, Faivre-Finn C, Kramer G et al (2007) Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357:664–672
Author information
Authors and Affiliations
Consortia
Additional information
Supported by an unrestricted educational grant from MSD Oncology
Clinical Guideline Working Group on behalf of the Spanish Society of Medical Oncology (SEOM)
Ramón Colomer, Emilio Alba, Antonio Llombart, Miguel Martín, Álvaro Rodríguez, Javier Salvador, Joan Albanell, Antonio González, Dolores Isla, María Lomas, César A. Rodríguez, José Manuel Trigo
Rights and permissions
About this article
Cite this article
Artal Cortés, Á., Dómine Gómez, M., Font Pous, A. et al. SEOM clinical guidelines for the treatment of small-cell lung cancer. Clin Transl Oncol 12, 27–31 (2010). https://doi.org/10.1007/s12094-010-0463-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-010-0463-2